In a previous study without clinical follow-up, we have shown that isolated CIS lesions are characterized by the expression of luminal markers including KRT20 and GATA3, whereas lacking the expression of the basal cytokeratins KRT5/6 and KRT14 in the majority of samples [14]. The gene discussed is GATA3; the disease is in situ carcinoma.